Abiraterone Reduced Morbidity in MCRPC Patients

Treatment with both drugs also delayed times to opiate use and chemotherapy, was associated with improved quality of life measures, and remained safe and well tolerated, said Dr. Dana E. Rathkopf, the...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news